When in hypoxia, Gal-1 expression increases, and this increased expression is associated with the secretion of proteins that modulate the immune response, assuming an active role in the malignant progression and therapeutic response of HNSCC [9]. The gene discussed is GAL; the disease is head and neck squamous cell carcinoma.